The post-US election rally continued into the new week, though only partially. The Dow rose another 0.68% or 300 points to a new high of almost 44,300 while the TSX advanced 0.12% nearly its own new high. TSX sectors were split, with tech and financials offsetting losses in materials and health care. <\/p>\n\n\n\n
Major movers on Bay Street were Onex<\/a> up 6.53%, Kinross Gold<\/a> -9.62%, B2Gold<\/a> -4.62%, BlackBerry<\/a> 4.31% and Lightspeed<\/a> 4.09%. Gold slid 2.3% to US$2,622 while WTI crude slipped over 3% to US$68.25.<\/p>\n\n\n\n On Wall Street, the S&P and Nasdaq were flat as drug companies dominated headlines. AbbVie<\/a> tumbled 12.57% after it announced disappointing trial results of its schizophrenia drug. In contrast, Bristol-Myers Squibb<\/a>‘s stock rocketed 10.49% on the news, driven by the strength of its rival drug, already approved by the FDA. Other notables included Albemarle<\/a>, rallying 9.67%, Tesla<\/a> 8.96% and Moderna<\/a> -8.71%. Bitcoin<\/a> continued its run by leaping 10% to US$87,925. Finally, the U.S. 10-year yield hovered at 4.3%.<\/p>\n\n\n\n 🏛 Onex Corp\u00a0(ONEX-T)<\/a> +6.53%<\/p>\n\n\n\n 🥇 Kinross Gold\u00a0(K-T)<\/a> -9.62%<\/p>\n\n\n\n 🥇 B2Gold Corp.\u00a0(BTO-T)<\/a> -4.62%<\/p>\n\n\n\n 📱 BlackBerry\u00a0(BB-T)<\/a> +4.31%<\/p>\n\n\n\n 💾 Lightspeed Commerce Inc\u00a0(LSPD-T)<\/a> +4.09%<\/p>\n\n\n\n 💊 AbbVie Inc.\u00a0(ABBV-N)<\/a> -12.57%<\/p>\n\n\n\n 💊 Bristol Myers Squibb\u00a0(BMY-N)<\/a> +10.49%<\/p>\n\n\n\n ⛏ Albemarle Corp\u00a0(ALB-N)<\/a> +9.67%<\/p>\n\n\n\n 🚗 Tesla Inc\u00a0(TSLA-Q)<\/a> +8.96%<\/p>\n\n\n\n